These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 5019442)

  • 1. [Bacteriostatic activity of blood and tubazid blood levels after administration of tuberculostatic drugs by various routes (experimental and clinical study)].
    Voĭtova DI; Vishnevskiĭ BI
    Antibiotiki; 1972 Jan; 17(1):85-8. PubMed ID: 5019442
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood bacteriostatic activity in pulmonary tuberculosis patients undergoing treatment with drugs of the 1st and 2d series].
    Alekseevskaia KP
    Probl Tuberk; 1972; 50(6):48-52. PubMed ID: 5051126
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bacteriostatic activity of blood in pulmonary tuberculosis after administration of different drug combinations].
    Mkrtchian SV; Shmeleva VI; Utkin VV
    Probl Tuberk; 1976; 3():67-70. PubMed ID: 967863
    [No Abstract]   [Full Text] [Related]  

  • 4. [Basis for the administration of streptomycin and isoniazid in ultrasonic aerosols in the treatment of intrathoracic tuberculosis].
    Semenova EV
    Antibiotiki; 1977 May; 22(5):469-71. PubMed ID: 879731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tuberculostatic test in the treatment of pulmonary tuberculosis with 1st and 2d class drugs].
    Gur'ian IE; Svitneva AS; Tarasova EF
    Probl Tuberk; 1971; 49(12):33-6. PubMed ID: 5003602
    [No Abstract]   [Full Text] [Related]  

  • 6. [Leukergy in patients with pulmonary tuberculosis treated for the first time with antitubercular drugs].
    Przemyska B
    Gruzlica; 1967; 35(11):1169-74. PubMed ID: 6063620
    [No Abstract]   [Full Text] [Related]  

  • 7. [Basis for intermittent therapy of tuberculosis].
    Vishnevskiĭ BI; Gunich LA
    Probl Tuberk; 1972; 50(11):75-8. PubMed ID: 4647623
    [No Abstract]   [Full Text] [Related]  

  • 8. [Methods of determining the bacteriostatic activity of the blood and the primary drug resistance of mycobacteria in pulmonary tuberculosis].
    Bibik NF
    Probl Tuberk; 1980 Feb; (2):63-6. PubMed ID: 6769111
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of short-term tuberculostatic treatment at the end of the therapeutic regimen].
    Tănase C; Baraneţchi C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983; 32(1):43-7. PubMed ID: 6312534
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bacterial excretion and the bacteriostatic activity of the blood in the chemotherapy of middle-aged and elderly tuberculosis patients].
    Ginzburg TS; Iakimets VP
    Probl Tuberk; 1983 May; (5):57-61. PubMed ID: 6408638
    [No Abstract]   [Full Text] [Related]  

  • 11. Isoniazid blood levels in patients with pulmonary tuberculosis at a tuberculosis referral center.
    Fahimi F; Kobarfard F; Tabarsi P; Hemmati S; Salamzadeh J; Baniasadi S
    Chemotherapy; 2011; 57(1):7-11. PubMed ID: 21124026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole blood bactericidal activity during treatment of pulmonary tuberculosis.
    Wallis RS; Vinhas SA; Johnson JL; Ribeiro FC; Palaci M; Peres RL; Sá RT; Dietze R; Chiunda A; Eisenach K; Ellner JJ
    J Infect Dis; 2003 Jan; 187(2):270-8. PubMed ID: 12552451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrazinamide serum levels in childhood tuberculosis.
    Thee S; Detjen A; Wahn U; Magdorf K
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1099-101. PubMed ID: 18713511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experience with single administration of 24-hour doses of tuberculostatic preparations in the treatment of pulmonary tuberculosis patients].
    Voitova DI
    Probl Tuberk; 1969; 47(11):26-9. PubMed ID: 5369223
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blood coagulation state in destructive pulmonary tuberculosis patients under different methods of chemotherapy].
    Sagalovich VIa; Beresneva RE; Ivanova VB
    Probl Tuberk; 1981 May; (5):30-4. PubMed ID: 7255385
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intermittent chemotherapy in adolescents with tuberculosis].
    Firsova VA; Smirnova MN; Grigor'eva ZP; Orlova LS
    Probl Tuberk; 1983 Feb; (2):37-40. PubMed ID: 6844329
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative study of specific blood activity in patients with fibrous-cavernous pulmonary tuberculosis during administration of different combinations of antibacterial preparations].
    Mkrtchian SV; Utkin VV; Egorkina ND
    Antibiotiki; 1970 Oct; 15(10):955-7. PubMed ID: 5487860
    [No Abstract]   [Full Text] [Related]  

  • 18. [Significance of blood bacteriological activity in assessing the effectiveness of therapy of distructive pulmonary tuberculosis].
    Anfilof'eva OIu; Gur'ian IE; Fedotova ZN
    Probl Tuberk; 1974; 52(5):36-8. PubMed ID: 4847877
    [No Abstract]   [Full Text] [Related]  

  • 19. The early bactericidal activity of amikacin in pulmonary tuberculosis.
    Donald PR; Sirgel FA; Venter A; Smit E; Parkin DP; Van de Wal BW; Mitchison DA
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):533-8. PubMed ID: 11409580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.